等待开盘 08-10 09:30:00 美东时间
+2.070
+3.80%
Wolfe Research analyst Andy Chen downgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Outperform to Peer Perform.
07-16 18:40
Ionis Pharmaceuticals (NASDAQ:IONS) affirms FY2026 sales outlook from $875.000 million-$900.000 million to $875.000 million-$900.000 million vs $893.928 million estimate.
07-10 18:14
Ionis and AstraZeneca said Phase 3 eplontersen missed its primary ATTR-CM endpoint, while secondary measures and safety remained favorable.
07-09 20:09
Ionis wins FDA approval for Tryngolza in severe hypertriglyceridemia and signs a Recordati licensing deal for zilganersen
06-26 00:25
GSK partnered with Sino Biopharmaceutical to advance hepatitis B drug bepirovirsen in China while launching its final buyback tranche.
05-12 00:03
In the latest quarter, 6 analysts provided ratings for Ionis Pharmaceuticals (N...
02-07 05:00
Ionis Pharmaceuticals Inc's (NYSE:IONS) short interest as a percent of float ha...
2025-12-04 23:01
Metagenomi reports curative-level FVIII activity for MGX-001 in primates and plans IND filing in 2026, extending cash runway into late 2027.
2025-11-13 01:09
Shares of Viasat Inc (NASDAQ:VSAT) rose sharply in pre-market trading after the...
2025-11-10 17:51
Ionis Pharmaceuticals (NASDAQ:IONS) is gearing up to announce its quarterly ear...
2025-10-29 02:02